AXSOME THERAPEUTICS, INC. Depreciation
AXSOME THERAPEUTICS, INC. (AXSM) reported Depreciation of $259.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-10
- AXSOME THERAPEUTICS, INC. depreciation for the quarter ending 2026-06-30 was $143.00K, a 19.17% increase year-over-year.
- AXSOME THERAPEUTICS, INC. depreciation for the quarter ending 2026-03-31 was $116.00K, a 22.15% decline year-over-year.
- AXSOME THERAPEUTICS, INC. depreciation for the quarter ending 2025-12-31 was $114.00K, a 11.63% decline year-over-year.
- AXSOME THERAPEUTICS, INC. depreciation for the quarter ending 2025-09-30 was $120.00K, a 8.40% decline year-over-year.
- AXSOME THERAPEUTICS, INC. depreciation for fiscal 2025 was $503.00K, a 5.45% decline from fiscal 2024.
- AXSOME THERAPEUTICS, INC. depreciation for fiscal 2024 was $532.00K, a 15.90% increase from fiscal 2023.
- AXSOME THERAPEUTICS, INC. depreciation for fiscal 2023 was $459.00K, a 74.52% increase from fiscal 2022.
- AXSOME THERAPEUTICS, INC. depreciation for fiscal 2022 was $263.00K, a 246.05% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $259.00K 10-Q · filed 2026-08-10 | $373.00K derived: sum of 3 quarters · filed 2026-08-10 | $493.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $116.00K 10-Q · filed 2026-05-04 | $230.00K derived: sum of 2 quarters · filed 2026-05-04 | $350.00K derived: sum of 3 quarters · filed 2026-05-04 | $470.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $234.00K derived: sum of 2 quarters · filed 2026-02-23 | $354.00K derived: sum of 3 quarters · filed 2026-08-10 | $503.00K 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | $120.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $240.00K derived: sum of 2 quarters · filed 2026-08-10 | $389.00K 10-Q · filed 2025-11-03 | $518.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $269.00K 10-Q · filed 2026-08-10 | $398.00K derived: sum of 3 quarters · filed 2026-08-10 | $529.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $149.00K 10-Q · filed 2026-05-04 | $278.00K derived: sum of 2 quarters · filed 2026-05-04 | $409.00K derived: sum of 3 quarters · filed 2026-05-04 | $549.00K derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $260.00K derived: sum of 2 quarters · filed 2026-02-23 | $400.00K derived: sum of 3 quarters · filed 2026-02-23 | $532.00K 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | $131.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $271.00K derived: sum of 2 quarters · filed 2025-11-03 | $403.00K 10-Q · filed 2025-11-03 | $536.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | $140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $272.00K 10-Q · filed 2025-08-04 | $405.00K derived: sum of 3 quarters · filed 2026-02-23 | $541.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | $132.00K 10-Q · filed 2025-05-05 | $265.00K derived: sum of 2 quarters · filed 2026-02-23 | $401.00K derived: sum of 3 quarters · filed 2026-02-23 | $501.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $269.00K derived: sum of 2 quarters · filed 2026-02-23 | $369.00K derived: sum of 3 quarters · filed 2026-02-23 | $459.00K 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | $136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $236.00K derived: sum of 2 quarters · filed 2024-11-12 | $326.00K 10-Q · filed 2024-11-12 | $411.00K derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $190.00K 10-Q · filed 2024-08-05 | $275.00K derived: sum of 3 quarters · filed 2025-02-18 | $349.00K derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | $90.00K 10-Q · filed 2024-05-06 | $175.00K derived: sum of 2 quarters · filed 2025-02-18 | $249.00K derived: sum of 3 quarters · filed 2025-02-18 | $316.00K derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $159.00K derived: sum of 2 quarters · filed 2025-02-18 | $226.00K derived: sum of 3 quarters · filed 2025-02-18 | $263.00K 10-K · filed 2025-02-18 | $263.44K 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $141.00K derived: sum of 2 quarters · filed 2023-11-06 | $178.00K 10-Q · filed 2023-11-06 | $178.11K 10-Q · filed 2022-11-07 | $208.69K derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2022-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $104.00K 10-Q · filed 2023-08-07 | $104.43K 10-Q · filed 2022-08-09 | $134.69K derived: sum of 3 quarters · filed 2024-02-23 | $161.93K derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2022-03-31 | $37.00K 10-Q · filed 2023-05-09 | $36.64K 10-Q · filed 2022-05-02 | $67.69K derived: sum of 2 quarters · filed 2024-02-23 | $94.92K derived: sum of 3 quarters · filed 2024-02-23 | $104.67K derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2021-12-31 | $30.70K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $57.92K derived: sum of 2 quarters · filed 2024-02-23 | $67.67K derived: sum of 3 quarters · filed 2024-02-23 | $76.00K 10-K · filed 2024-02-23 | $76.35K 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $27.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $36.98K derived: sum of 2 quarters · filed 2022-11-07 | $45.30K 10-Q · filed 2022-11-07 | $52.69K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $9.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $18.07K 10-Q · filed 2022-08-09 | $25.46K derived: sum of 3 quarters · filed 2023-02-28 | $30.98K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $8.33K 10-Q · filed 2022-05-02 | $15.71K derived: sum of 2 quarters · filed 2023-02-28 | $21.23K derived: sum of 3 quarters · filed 2023-02-28 | $26.75K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $7.38K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $12.90K derived: sum of 2 quarters · filed 2023-02-28 | $18.43K derived: sum of 3 quarters · filed 2023-02-28 | $23.86K 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $5.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $11.05K derived: sum of 2 quarters · filed 2021-11-08 | $16.48K 10-Q · filed 2021-11-08 | $21.87K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $5.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $10.96K 10-Q · filed 2021-08-09 | $16.35K derived: sum of 3 quarters · filed 2022-03-01 | $25.74K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $5.44K 10-Q · filed 2021-05-10 | $10.83K derived: sum of 2 quarters · filed 2022-03-01 | $20.22K derived: sum of 3 quarters · filed 2022-03-01 | $31.33K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $5.39K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $14.78K derived: sum of 2 quarters · filed 2022-03-01 | $25.89K derived: sum of 3 quarters · filed 2022-03-01 | $37.33K 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $9.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $20.50K derived: sum of 2 quarters · filed 2020-11-05 | $31.94K 10-Q · filed 2020-11-05 | $44.15K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $11.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $22.55K 10-Q · filed 2020-08-10 | $34.76K derived: sum of 3 quarters · filed 2021-03-01 | $47.83K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $11.44K 10-Q · filed 2020-05-11 | $23.65K derived: sum of 2 quarters · filed 2021-03-01 | $36.72K derived: sum of 3 quarters · filed 2021-03-01 | $48.44K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $12.21K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $25.28K derived: sum of 2 quarters · filed 2021-03-01 | $37.00K derived: sum of 3 quarters · filed 2021-03-01 | $48.94K 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $13.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $24.79K derived: sum of 2 quarters · filed 2019-11-07 | $36.73K 10-Q · filed 2019-11-07 | $48.00K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | $11.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $23.65K 10-Q · filed 2019-08-08 | $34.92K derived: sum of 3 quarters · filed 2020-03-12 | $45.71K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | $11.94K 10-Q · filed 2019-05-09 | $23.21K derived: sum of 2 quarters · filed 2020-03-12 | $33.99K derived: sum of 3 quarters · filed 2020-03-12 | $44.38K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | $11.27K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $22.06K derived: sum of 2 quarters · filed 2020-03-12 | $32.44K derived: sum of 3 quarters · filed 2020-03-12 | $42.56K 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | $10.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $21.17K derived: sum of 2 quarters · filed 2018-11-09 | $31.28K 10-Q · filed 2018-11-09 | $41.03K derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-06-30 | $10.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $20.50K 10-Q · filed 2018-08-08 | $30.25K derived: sum of 3 quarters · filed 2019-03-15 | $35.87K derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-03-31 | $10.11K 10-Q · filed 2018-05-08 | $19.86K derived: sum of 2 quarters · filed 2019-03-15 | $25.48K derived: sum of 3 quarters · filed 2019-03-15 | $28.48K derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2016-12-31 | $9.75K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $15.37K derived: sum of 2 quarters · filed 2019-03-15 | $18.37K derived: sum of 3 quarters · filed 2019-03-15 | $20.48K 10-K · filed 2019-03-15 | ||||
| 2016-09-30 | $5.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $8.62K derived: sum of 2 quarters · filed 2017-11-08 | $10.73K 10-Q · filed 2017-11-08 | $11.98K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $5.12K 10-Q · filed 2017-08-09 | $6.37K derived: sum of 3 quarters · filed 2018-03-07 | $7.49K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-03-31 | $2.11K 10-Q · filed 2017-05-09 | $3.36K derived: sum of 2 quarters · filed 2018-03-07 | $4.49K derived: sum of 3 quarters · filed 2018-03-07 | $5.35K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2015-12-31 | $1.25K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $2.37K derived: sum of 2 quarters · filed 2018-03-07 | $3.24K derived: sum of 3 quarters · filed 2018-03-07 | $3.54K 10-K · filed 2018-03-07 | ||||
| 2015-09-30 | $1.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $1.99K derived: sum of 2 quarters · filed 2016-11-14 | $2.29K 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | $865.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2016-08-09 | $1.17K 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | $304.00 10-Q/A · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |